Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hox genes are a subset of homeobox genes encoding transcription factors that bind DNA and regulate gene expression during development, ensuring the correct structures and organs form in the appropriate positions along the anterior-posterior axis[1][3][7]. The order and arrangement of Hox genes in their clusters is mirrored by their pattern of expression in the embryo (spatial and temporal colinearity), which is crucial for body plan specification in animals[5][7][1]. Dysregulation or mutation of Hox genes is linked to cancer, developmental disorders, and congenital malformations. These genes are not receptors, enzymes, or traditional pharmacological drug targets but serve as master regulators of gene networks that govern cell fate and body patterning[7][3][1].
N/A (No drugs have a mechanism of action specific to Hox gene family)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hox gene family (Hox (or HOX, where individual genes may be abbreviated as HOXA1, HOXB9, etc.)).